ADVERTISING FEATURE
s y
ortant in busy operating rooms a user-friendly interface and a nfusion data at a glance.
patient safety is a concern. broad range of plasma (PK) and . The Eleveld Propofol and Eleveld y TCI models able to provide hey help anaesthetists meet IV afe, timely and accurate way3
.
a through the AlarisTM ospital information systems. pump event logs and the
ere in the hospital improves clinical workflows as pumps
Increased medication safety for all population The BD AlarisTM
neXus PK syringe pump has
However, they may just support with the development of the business case. From BD you’ll always have someone like me to lead the project, plus your sales representative. Our Managed Service Team oversee all BDs VBP contracts. For continuity you have a single point of contact, in the form of a Customer Success Manager, and regular review meetings. If your circumstances change, or a KPI is not working, our contracts are flexible. In fact, I’ve never seen one stay the same! We have robust change control procedures and will manage everything transparently and together.
patent pending medication safety to minimise the potential for programming errors, especially when setting up infusions for children. This technology automatically adjusts the suggested default settings for height and weight based on the patient’s age that is entered when using the Eleveld propofol and Eleveld remifentanil TCI model. .
nider (v0.1) TW, Minto CF, Struys MM, Absalom AR. The Safety of Target- :79-85. doi: 10.1213/ANE.0000000000001005. PMID: 26516801. 2 The Joint nuary 2021. 3 Vandemoortele O, Hannivoort LN, Vanhoorebeeck F, Struys
Does everything happen at once? In most cases there’s a staggered implementation plan. We find out what’s happening across the Trust or ICS that could divert resources or attention for example, the implementation of a new IT system, and work around it. Getting everything up and running depends on what’s included and who’s involved. We work at your pace.
netic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic 1(9):2487. doi: 10.3390/jcm11092487. PMID: 35566617; PMCID: PMC9101974.
gle, Wokingham, RG41 5TS
New TCI drug models* • Dexmedetomidine (Hannivoort-Colin) • Propofol (Eleveld), • Remifentanil (Eleveld), • Remifentanil (Kim-Obara-Egan) * refer to specifications for full list of drug models.
we can help you save huge amounts of time and money. For example, reducing reliance on agency staff, even negating the need to fill open positions. We’ll also ensure the right accounting rules are applied; minimising capital spend. And you’ll have peace of mind knowing the price for new devices is secured for future procurement.
Thanks Tom, so how would you sum up? Infusion as a Service is flexible, scalable, and commercially savvy. It makes life easier for EBMEs with Plug & Play, and easier for nurses with Swap-In Swap-Out. In these challenging and uncertain times, our partnerships might be just what you’ve been looking for.
To find out more contact:
uk-marketing@bd.com NPM-2138
a-uk f Becton, Dickinson and Company. © 2022 BD. All rights reserved. (BD-91562, August 2023)
Will working in partnership with BD prove better value for money? Yes. Whilst savings might not be realised directly from product purchases, our partnerships help everyone get a better view of the service. So,
TM
neXus PK Syringe Pump
and effective anaesthesia naesthesia requires precise devices
1 . Built on the BD Alaris TM neXus
Xus PK syringe pump is designed to offer timely, precise and hildren and adults.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
